Dentsply Sirona Inc. (XRAY): Price and Financial Metrics

XRAY POWR Grades

• XRAY scores best on the Value dimension, with a Value rank ahead of 93.33% of US stocks.
• The strongest trend for XRAY is in Momentum, which has been heading down over the past 179 days.
• XRAY ranks lowest in Momentum; there it ranks in the 16th percentile.

XRAY Stock Summary

• XRAY has a market capitalization of $10,818,975,488 -- more than approximately 82% of US stocks.
• XRAY's went public 30.95 years ago, making it older than 83.77% of listed US stocks we're tracking.
• Over the past twelve months, XRAY has reported earnings growth of -5,216.67%, putting it ahead of merely 0.33% of US stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to DENTSPLY SIRONA Inc are TNC, IAC, MNTX, VERO, and ASTE.
• XRAY's SEC filings can be seen here. And to visit DENTSPLY SIRONA Inc's official web site, go to www.dentsplysirona.com.

XRAY Valuation Summary

• XRAY's EV/EBIT ratio is 29.3; this is 0% higher than that of the median Healthcare stock.
• XRAY's price/sales ratio has moved up 0.8 over the prior 243 months.
• Over the past 243 months, XRAY's price/sales ratio has gone up 0.8.

Below are key valuation metrics over time for XRAY.

XRAY Growth Metrics

The 3 year net cashflow from operations growth rate now stands at 9.6%.
• The year over year cash and equivalents growth rate now stands at 34.8%.
• Its year over year price growth rate is now at 67.18%.

XRAY's revenue has moved up $1,460,394,000 over the prior 70 months.

The table below shows XRAY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	4,251	657	421
2021-09-30	4,245.3	698.5	417.5
2021-06-30	4,071.1	733.6	368.3
2021-03-31	3,494.7	694.7	173.9
2020-12-31	3,342	635	-83
2020-09-30	3,371.2	670.8	-79.2

XRAY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XRAY has a Quality Grade of C, ranking ahead of 67.88% of graded US stocks.
• XRAY's asset turnover comes in at 0.443 -- ranking 108th of 186 Medical Equipment stocks.
• ZBH, PEN, and IVC are the stocks whose asset turnover ratios are most correlated with XRAY.

The table below shows XRAY's key quality metrics over time.